Claims for Patent: 8,399,640

Summary for Patent: 8,399,640

Title:	Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 encoding human SMS3
Abstract:	Provided herein are isolated genomic polynucleotide fragments from the from the p15 region of chromosome 11 encoding human SMS3 (SMS3) and methods of use.
Inventor(s):	Ryan; James (Augusta, GA)
Assignee:	Ryogen LLC (Suffern, NY)
Application Number:	13/239,327
Patent Claims:	1. An isolated polynucleotide selected from the group consisting of: (a) an isolated polynucleotide consisting of a nucleic acid sequence which is at least 99% identical to the polynucleotide of SEQ ID NO: 8; (b) a polynucleotide fragment of (a) comprising at least nucleotides 18959-21311 of SEQ ID NO:8 or (c): a reverse strand of the polynucleotides of (a) or (b). 2. A nucleic acid construct comprising the polynucleotide of claim 1. 3. An expression vector comprising the polynucleotide of claim 1. 4. A recombinant host cell comprising the polynucleotide of claim 1. 5. An isolated polynucleotide at least 100 nucleotides in length identical to a region of SEQ ID NO: 8, said region selected from the group consisting of a 5'-noncoding region, an intron, a 3'-non-coding region and a contiguous coding and non-coding region of SEQ ID NO:8 or reverse strand of said polynucleotide. 6. The isolated polynucleotide of claim 5, wherein the 5'-noncoding region consists of nucleotides 21312-25970 of SEQ ID NO:8, the intron is selected from the group consisting of nucleotides 20119-21260 and 19211-20022 of SEQ ID NO:8 and a 3'-noncoding region consists of nucleotides 1-18958 of SEQ ID NO:8. 7. A composition comprising the polynucleotide of claim 1 and a carrier or diluent. 8. A composition comprising the polynucleotide of claim 5 and a carrier or diluent. 9. A kit comprising the polynucleotide of claim 1. 10. A kit comprising the polynucleotide of claim 5. 11. A method for detecting the presence or absence of a nucleic acid sequence of SEQ ID NO: 8 or its complementary sequence in a sample, said method comprising contacting the sample with the polynucleotide of claim 5. 12. A method of detecting the presence or absence of a variant of a nucleic acid sequence of SEQ ID NO: 8 or its complementary sequence in a sample using the polynucleotide of claim 1. 13. A method for obtaining the polynucleotide of claim 1 comprising (a) isolating genomic polynucleotide from a subject; (b) providing primers, probes and optionally polymerase, wherein said primers or probes are at least 100 nucleotides in length identical to a region of SEQ ID NO: 8, said region selected from the group consisting of a 5' noncoding region, an intron, a 3'-non-coding region and a contiguous coding and non-coding region of SEQ ID NO:8 or reverse strand of said regions and (c) incubating (a) and (b) under conditions promoting the isolation of said polynucleotide. 14. A method for obtaining the polynucleotide of claim 5 comprising (a) isolating genomic polynucleotide from a subject; (b) providing primers, probes and optionally polymerase, wherein said primers or probes are at least 100 nucleotides in length identical to a region of SEQ ID NO: 8, said region selected from the group consisting of 5'' noncoding region, an intron, a 3'-non-coding region and a contiguous coding and non-coding region of SEQ ID NO:8 or reverse strand of said regions and (c) incubating (a) and (b) under conditions promoting the isolation of said polynucleotide. 15. The polynucleotide according to claim 1, wherein said polynucleotide is DNA or RNA. 16. An isolated polynucleotide consisting of a 5'-noncoding region, an intron, a 3'-non-coding region or a contiguous coding and non-coding nucleic acid region of SEQ ID NO:8 or reverse strand of said polynucleotide, wherein the 5'-noncoding region consists of nucleotides 21312-25970 of SEQ ID NO:8, the intron is selected from the group consisting of nucleotides 20119-21260 and 19211-20022 of SEQ ID NO:8 and a 3'-noncoding region consists of nucleotides 1-18958 of SEQ ID NO:8. 17. An isolated polynucleotide fragment of the isolated polynucleotide of claim 16, wherein said fragment is at least 500 nucleotides in length. 18. The method according to claim 13, wherein said polynucleotide is DNA or RNA. 19. The method according to claim 14, wherein said polynucleotide is DNA or RNA. 20. The polynucleotide according to claim 5, wherein said polynucleotide is DNA or RNA. 21. The polynucleotide according to claim 16, wherein said polynucleotide is DNA or RNA. 22. The kit comprising the polynucleotide of claim 16.

Details for Patent 8,399,640

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2020-10-31
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2020-10-31
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2020-10-31